We are live on
!
Find out more
NPF
Norris Perne & French Portfolio holdings
AUM
$2.34B
Turnover
18.02%
1-Year Est. Return
32.04%
This Fund
S&P 500
This Quarter
Est. Return
+8.37%
1 Year Est. Return
+32.04%
3 Year Est. Return
+79.89%
5 Year Est. Return
+104.74%
10 Year Est. Return
+469.51%
AUM
$533M
AUM Growth
+$48M
(+9.9%)
Cap. Flow
+$10.2M
Cap. Flow
% of AUM
1.9%
Top 10 Holdings %
Top 10 Hldgs %
25.48%
Holding
205
New
12
Increased
53
Reduced
85
Closed
9
Avg Time Held
0.5
years
Top 10 Avg Time Held
0.4
years
Top 20 Avg Time Held
0.4
years
Top Buys
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Infosys
INFY
|
+$1.18M |
| 2 |
Perficient Inc
PRFT
|
+$1.08M |
| 3 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$1.04M |
| 4 |
JPMORGAN CHASE & CO. Depositary Shares, each representing a 1/400 interest in a share of 5.45% Non-C
JPM.PRA.CL
|
+$999K |
| 5 |
GIVN
GIVEN IMAGING LTD
GIVN
|
+$811K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 17.16% |
| 2 | Industrials | 16.7% |
| 3 | Healthcare | 15.65% |
| 4 | Technology | 13% |
| 5 | Consumer Staples | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Cognizant
CTSH
$29.4B
| $14.9M | 2.8% |
295,716
-14,754
| -5% | -$672K |
2013 Q2
2 quarters
|
|
2
Parker-Hannifin
PH
$122B
| $14.9M | 2.79% |
115,503
+956
| +0.8% | +$111K |
2013 Q2
2 quarters
|
|
3
Apple
AAPL
$5.04T
| $14.4M | 2.7% |
717,612
+12,656
| +2% | +$239K |
2013 Q2
2 quarters
|
|
4
Qualcomm
QCOM
$188B
| $14.1M | 2.64% |
189,444
-4,703
| -2% | -$332K |
2013 Q2
2 quarters
|
|
5
GE Aerospace
GE
$328B
| $13.3M | 2.49% |
98,968
+3,287
| +3% | +$414K |
2013 Q2
2 quarters
|
|
|
VAR
6
DELISTED
Varian Medical Systems, Inc.
VAR
| $12.2M | 2.3% |
179,757
+9,073
| +5% | +$604K |
2013 Q2
2 quarters
|
|
7
Boeing
BA
$149B
| $12M | 2.25% |
87,819
+610
| +0.7% | +$79.3K |
2013 Q2
2 quarters
|
|
8
Alphabet (Google) Class C
GOOG
$4.15T
| $12M | 2.24% |
428,199
+93,589
| +28% | +$2.37M |
2013 Q2
2 quarters
|
|
9
Berkshire Hathaway Class B
BRK.B
$1.13T
| $11.9M | 2.23% |
100,336
+240
| +0.2% | +$27.8K |
2013 Q2
2 quarters
|
|
10
Emerson Electric
EMR
$89.9B
| $11.8M | 2.21% |
167,820
-546
| -0.3% | -$36.5K |
2013 Q2
2 quarters
|
|
11
Jacobs Solutions
J
$16.5B
| $11.7M | 2.2% |
225,458
+25,180
| +13% | +$1.25M |
2013 Q2
2 quarters
|
|
12
PepsiCo
PEP
$179B
| $11.2M | 2.09% |
134,675
+2,522
| +2% | +$209K |
2013 Q2
2 quarters
|
|
13
Huntsman Corp
HUN
$1.52B
| $10.3M | 1.93% |
417,735
-5,816
| -1% | -$133K |
2013 Q2
2 quarters
|
|
14
Neogen
NEOG
$2.59B
| $10.2M | 1.91% |
595,056
+5,532
| +0.9% | +$96.2K |
2013 Q2
2 quarters
|
|
15
ConocoPhillips
COP
$175B
| $10.1M | 1.9% |
143,124
+7,774
| +6% | +$558K |
2013 Q2
2 quarters
|
|
16
NOV
NOV
$6.76B
| $9.82M | 1.84% |
136,997
+3,288
| +2% | +$239K |
2013 Q2
2 quarters
|
|
17
DELISTED
EMC CORPORATION
EMC
| $9.74M | 1.83% |
387,256
+14,435
| +4% | +$350K |
2013 Q2
2 quarters
|
|
18
DELISTED
Praxair Inc
PX
| $9.62M | 1.8% |
73,985
+1,673
| +2% | +$209K |
2013 Q2
2 quarters
|
|
19
Bristol-Myers Squibb
BMY
$124B
| $9.27M | 1.74% |
174,490
+2,320
| +1% | +$118K |
2013 Q2
2 quarters
|
|
|
SIRO
20
DELISTED
SIRONA DENTAL SYSTEMS INC COM STK
SIRO
| $9.25M | 1.74% |
131,811
+67,605
| +105% | +$4.7M |
2013 Q3
1 quarter
|
|
21
Johnson & Johnson
JNJ
$613B
| $9.01M | 1.69% |
98,402
-1,424
| -1% | -$131K |
2013 Q2
2 quarters
|
|
22
Stryker
SYK
$113B
| $8.79M | 1.65% |
117,040
-2,415
| -2% | -$176K |
2013 Q2
2 quarters
|
|
23
eBay
EBAY
$53.7B
| $8.75M | 1.64% |
379,138
+18,129
| +5% | +$401K |
2013 Q2
2 quarters
|
|
24
ExxonMobil
XOM
$728B
| $8.32M | 1.56% |
82,243
-1,613
| -2% | -$149K |
2013 Q2
2 quarters
|
|
|
ITC
25
DELISTED
ITC HOLDINGS CORP
ITC
| $8.31M | 1.56% |
260,331
+7,563
| +3% | +$241K |
2013 Q2
2 quarters
|
|
Similar funds
OCMI
NP
Norris Perne & French's Q4 2013 Portfolio in Review
As of Q4 2013, Norris Perne & French held 205 positions worth $533M, up 9.9% from $485M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Norris Perne & French's Q4 2013 filing shows 12 new, 53 increased, 85 reduced and 9 closed positions. Its largest new stake was WELLS FARGO & COMPANY Depositary Shares, each representing a 1/1,000th interest in a share of 6.625% Fixed-to-Floating Rate Non-Cumulative Perpetual Class A Preferred Stock, Series R: 88,700 shares worth $2.28M. The largest sale was Infosys, an estimated $1.18M.
By sector, the portfolio is most concentrated in Miscellaneous at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Healthcare.
- Norris Perne & French's largest Q4 2013 buy was WELLS FARGO & COMPANY Depositary Shares, each representing a 1/1,000th interest in a share of 6.625% Fixed-to-Floating Rate Non-Cumulative Perpetual Class A Preferred Stock, Series R: 88,700 shares worth $2.28M.
- Norris Perne & French added most to SIRONA DENTAL SYSTEMS INC COM STK in Q4 2013, an estimated $4.7M increase.
- Norris Perne & French's biggest Q4 2013 reduction was Perficient Inc, cutting an estimated $1.08M.
- Norris Perne & French fully exited Infosys in Q4 2013, selling an estimated $1.18M.
- Norris Perne & French's ten largest holdings make up 25% of its $533M portfolio in Q4 2013.
- Norris Perne & French opened 12 new positions and closed 9 in Q4 2013.
- Norris Perne & French's portfolio value rose 9.9% quarter-over-quarter to $533M.
Based on Norris Perne & French's 13F filing for Q4 2013, filed 23 Jan 2014.